<?xml version="1.0" encoding="UTF-8"?>
<p id="p0100">The RNA-targeting CRISPR associated enzyme Cas13 has recently been adapted for rapid and portable sensing of nucleic acids [
 <xref rid="bib43" ref-type="bibr">43</xref>,
 <xref rid="bib44" ref-type="bibr">44</xref>]. Zhang’s group demonstrated that Cas13 can be programmed to target and destroy the genomes of diverse mammalian single stranded RNA viruses (
 <xref rid="fig3" ref-type="fig">Fig. 3</xref>) [
 <xref rid="bib45" ref-type="bibr">45</xref>]. They developed a platform termed SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) that combined isothermal preamplification with Cas13 to detect single molecules of RNA or DNA [
 <xref rid="bib46" ref-type="bibr">46</xref>]. It can detect Dengue or Zika virus single-stranded RNA as well as mutations in patient liquid biopsy samples. Their lately protocol for COVID-19 entitled “A protocol for detection of COVID-19 using CRISPR diagnostics” has been reported on website (
 <ext-link ext-link-type="uri" xlink:href="https://broad.io/sherlockprotocol" id="intref0015" xmlns:xlink="http://www.w3.org/1999/xlink">https://broad.io/sherlockprotocol</ext-link>), which may provide some reference points for researchers interested in further advancing this diagnostics system, highlighting its potential as a multiplexable, portable, rapid, and quantitative detection platform of nucleic acids.
</p>
